Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Mapp Biopharmaceutical, Inc.

Year Established:
2003
Website:
mappbio.com
Company Type:
Small Business (1-10M TTM Revenue)

Mapp Biopharmaceutical was founded in 2003 by Drs. Kevin Whaley and Larry Zeitlin to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

The company has been developing an Ebola therapy for more than a decade and has been working with the United States and Canadian governments to develop this therapy.

As these products transition to clinical evaluation, LeafBio assumes ownership and commercialization responsibilities.

Site Badges
Mapp Biopharmaceutical, Inc.
6160 Lusk Boulevard San Diego, CA, 92121 United States

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service